Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial - Concepedia

Concepedia

Publication | Closed Access

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

100

Citations

37

References

2008

Year

Robert M. Califf, Mitradev Boolell, Steven M. Haffner, M. Angelyn Bethel, John J.V. McMurray, Anil Duggal, Rury R. Holman

American Heart Journal

Metabolic SyndromeNon-pharmacological InterventionDiabetes ManagementCardiovascular DiseaseDiabetesImpaired Glucose ToleranceDiabetes MellitusMedicine

References

	Year	Citations

Page 1